Ascendis Pharma A (ASND) EBIT Margin Growth (5y) (2019 - 2026)
Powered by 
Analysis
Ascendis Pharma A (ASND) EBIT Margin Growth (5y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ascendis Pharma A | 16.39 Bn | 15.45 Bn | 362.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 14,239.00 |
| Sep 30, 2025 | 286,423.00 |
| Jun 30, 2025 | 574,275.00 |
| Mar 31, 2025 | 318,689.00 |
| Dec 31, 2024 | 16,055.00 |
| Sep 30, 2024 | 224,088.00 |
| Jun 30, 2024 | 123,602.00 |
| Mar 31, 2024 | 98,830.00 |
| Dec 31, 2023 | 11,184.00 |
| Sep 30, 2023 | 19.12 Mn |
| Jun 30, 2023 | 25.22 Mn |
| Mar 31, 2023 | 12.52 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 630,675.00 |
| Jun 30, 2022 | 325,217.00 |
| Mar 31, 2022 | 445,854.00 |
| Dec 31, 2021 | 200,102.00 |
| Sep 30, 2021 | -717,084.00 |